Intravascular delivery of particulate systems: does geometry really matter?
- PMID: 18712584
- DOI: 10.1007/s11095-008-9697-x
"VSports" Intravascular delivery of particulate systems: does geometry really matter?
"V体育官网" Abstract
In cancer therapy and imaging, the systemic passive delivery of particulate systems has relied on the enhanced permeability and retention (EPR) effect: sufficiently small particles can cross the endothelial fenestrations and accumulate in the tumor parenchyma VSports手机版. The vast majority of man-made particulates exhibit a spherical shape as a result of surface energy minimization during their synthesis. The advent of phage display libraries, which are revealing the extraordinary molecular diversity of endothelial cells, and the development of processes for fabricating particles with shapes other than spherical are opening the path to new design solutions for systemically administered targeted particulates. In this paper, the role of particle geometry (i. e. , size and shape) is discussed at the tissue and cellular scales. Emphasis is placed on how the synergistic effect of particle geometry and molecular targeting can enhance the specificity of delivery. The intravascular delivery process has been broken into three events: margination, firm adhesion and control of internalization. Predictions from mathematical models and observations from in-vitro experiments were used to show the relevance of particle geometry in systemic delivery. Rational design of particulate systems should consider, beside the physico-chemical properties of the surface coatings, geometrical features as size and shape. The integration of mathematical modeling with in-vitro and in-vivo testing provides the tools for establishing a rational design of nanoparticles. .
VSports app下载 - References
-
- Biomaterials. 2008 Jan;29(3):377-84 - PubMed
-
- Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20 - PubMed
-
- Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4607-12 - PubMed (VSports注册入口)
-
- Nat Nanotechnol. 2008 Mar;3(3):131-2 - PubMed
-
- Curr Pharm Biotechnol. 2005 Feb;6(1):35-47 - PubMed
Publication types
- V体育平台登录 - Actions
- Actions (VSports app下载)
MeSH terms
- "VSports" Actions
- "VSports最新版本" Actions
- "VSports在线直播" Actions
- "V体育ios版" Actions
- Actions (VSports手机版)
- "V体育安卓版" Actions
- "V体育安卓版" Actions
Substances
- "V体育2025版" Actions
LinkOut - more resources
Full Text Sources
"VSports在线直播" Other Literature Sources
